News & Insights / April 20, 2020.
“Dear Staff,
Primarily, I want to say that you are safe with us. NoyMed does not plan to lockout its workflow or downsize its staff. The key to our success has been the energy that we have together. I encourage everyone to come together to power that energy. We are a great team and together we are much stronger.
We need to empower each other and navigate our energy towards the growth of our company in this dramatic time. At NoyMed, we are ready handle the turbulence and transformations in our industry, and move forward will full steam ahead by meeting the challenges and being at the forefront of the current developments in our great and perspective industry.
We have developed a great new (COVID-19 related) crisis management policy and action plan that will enable us to respond to the potential downward changes in the industry and continue operations business as usual for long enough to come out as winners. However, we hope situation improves and there will not be any necessity to enact the plan.
Additionally, this COVID-19 situation creates new great opportunities and opens up new markets for us. I am confident that we will seize these new opportunities and come out of this situation as an even stronger and larger company – together and with the help of our brilliant and talented employees!”
Best regards
Armen Margaryan
CEO
NoyMed LLC
- NoyMed CRO – Your Trusted Partner for Outsourcing Solutions in Challenging Environments
- Outsourcing in Biotech and Pharma: Overcoming Challenges with Strategic Collaboration
- Comparing SAS vs R for Clinical Trials Statistical Programming: Will R Replace SAS in 2024?
- The Partnership of 2 CROs: Providing Collaborative Services and Solutions
- Maximizing the Efficiency in Clinical Trials: Cutting Costs, Automating Tasks, and Accelerating Project Delivery Timelines (2024)